Sign In
Buy HRTX
$0.447
-0.0032 (-0.711%)
At Close: Jun 03, 2026
Amalgamated Bank Increases Position in Heron Therapeutics Inc (NASDAQ:HRTX)
08:30am, Sunday, 29'th Mar 2020
Amalgamated Bank grew its stake in Heron Therapeutics Inc (NASDAQ:HRTX) by 20.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fir
Heron Therapeutics (NASDAQ:HRTX) Shares Up 5.7%
07:25am, Thursday, 26'th Mar 2020
Heron Therapeutics Inc (NASDAQ:HRTX)’s stock price shot up 5.7% during mid-day trading on Tuesday . The stock traded as high as $11.90 and last traded at $11.50, 2,094,109 shares were traded during
Pet owners find many vets are now doing curbside service
04:06pm, Tuesday, 24'th Mar 2020
How metro Atlanta vets are adapting to provide care for pets amid coronavirus crisis
Credit Suisse AG Acquires 112,634 Shares of Heron Therapeutics Inc (NASDAQ:HRTX)
11:32am, Sunday, 22'nd Mar 2020
Credit Suisse AG boosted its holdings in shares of Heron Therapeutics Inc (NASDAQ:HRTX) by 154.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and
AlphaCrest Capital Management LLC Buys New Shares in Heron Therapeutics Inc (NASDAQ:HRTX)
08:20am, Sunday, 22'nd Mar 2020
AlphaCrest Capital Management LLC bought a new stake in shares of Heron Therapeutics Inc (NASDAQ:HRTX) during the fourth quarter, according to the company in its most recent filing with the Securities
Spotlight On Nike, Micron, Disney And Jobless Claims
12:37pm, Saturday, 21'st Mar 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
Head to Head Comparison: Revance Therapeutics (NASDAQ:RVNC) & Heron Therapeutics (NASDAQ:HRTX)
05:08am, Saturday, 21'st Mar 2020
Revance Therapeutics (NASDAQ:RVNC) and Heron Therapeutics (NASDAQ:HRTX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the streng
Key events next week - healthcare
03:23pm, Friday, 20'th Mar 2020
Noteworthy events during the week of March 22 - 28 for healthcare investors (some could be canceled/postponed due to COVID-19).SUNDAY (3/22): European Society for Blood and Marrow Transplantation Annu
Bank of Montreal Can Sells 15,758 Shares of Heron Therapeutics Inc (NASDAQ:HRTX)
09:32am, Friday, 20'th Mar 2020
Bank of Montreal Can trimmed its position in shares of Heron Therapeutics Inc (NASDAQ:HRTX) by 51.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Sec
Will COVID-19 Derail New Drugs?
11:30am, Wednesday, 18'th Mar 2020
Disruptions in clinical trials and delayed regulatory decisions could slow the rate of new drug approvals.
ArrowMark Colorado Holdings LLC Cuts Stock Holdings in Heron Therapeutics Inc (NASDAQ:HRTX)
09:38am, Wednesday, 18'th Mar 2020
ArrowMark Colorado Holdings LLC reduced its position in shares of Heron Therapeutics Inc (NASDAQ:HRTX) by 1.4% in the 4th quarter, according to the company in its most recent 13F filing with the Secur
Heron Therapeutics (NASDAQ:HRTX) Shares Down 10.9%
08:02am, Friday, 13'th Mar 2020
Heron Therapeutics Inc (NASDAQ:HRTX)’s stock price fell 10.9% during trading on Wednesday . The company traded as low as $13.62 and last traded at $13.64, 1,799,235 shares traded hands during mid-da
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
12:00am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
Franklin Resources Inc. Grows Holdings in Heron Therapeutics Inc (NASDAQ:HRTX)
11:32am, Tuesday, 10'th Mar 2020
Franklin Resources Inc. grew its holdings in shares of Heron Therapeutics Inc (NASDAQ:HRTX) by 19.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and
